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bweasing numbers of patients are oow undergoing a second 
coroomy bypass operation because of progressive coroow 
atherosclerosis and grail failure. Sophenous vein grafts. in 
particular, are at risk for both early and late galI failure. 
Pooled dale indicate that the I-, S- to 7- and IO-year 
cumulative occlusion rates for saphenous vein grafts are 16% 
to 26% 2.5% to 35% and 40% to 50% respectively (I). 
Data such as these have led to the recommendation to 
replace all vein gmRs that are older than 5 years dorim 
coronary reopemtioo whether or not they have severe 
stenoses (X3). Not infrequently, patients requiring a corn-- 
nary reopemtion have one “I more vein grafts that remain 
widely patent. The long-term behavior of these aogiograph- 
icallv wrmal or onlv minimtiy diseased veio wafts has not 
beei well elucidated. These grafts, having demwstmted 
early durability, may remain patent for long periods of time. 
This study was conducted to determine the loog-term 
Center, ButTatv, New York. 
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patency of saphenous vein gmtts that ore known to be 
aogiagmphically normal or only minimally diseased 5 years 
after operation. This information may provide useful insight 
on the proper management of minimally diseased gifts 
during reoperatiw. 
~tieot seleeth The cardiac cathetetizoti”” records of 
the Veterans .&Sirs Medical Center. BtdM”. New York for 
the years IWI throqh KG37 were &iewed to identify those 
patients who had had a c”mtwy angMgram z4Q months 
after coronary bypass surgery. The ci”eaogi”grams of these 
patien’ were reviewed and the status of the grafts verified. 
F’otiems who had at least one aogiogmphically oormal or 
only mioimally diseased sqheoous vein @aft were consid- 
ered eligible for btcluoion in the initial analysis. Normal vein 
gmns were detined as those having a smooth contour 
throughout their course, and minimally diswed #atIs were 
defined as those with a maximal lumen diameter narrowing 
of ~3.5% (Fig. I). Patients who had undergone interim 
aogioplasty of the patent vein gmft were excluded. 
A total of 132 patients, all male. were eligible for late 
aogiographic follow-up (Table I). Thirty-five of these 132 
patients died before appropriate follow-Up could be ob- 
F@e 1. Ae&nm showing a” example of a normal (top) and a 
minimally diseased (bo(tao) aaphenous vein graft. 
tained. Sixteen patients refused toundergoanothercoronary 
angiographic procedure and 12 patients were lost to follow- 
up. Coronary aagiography was deemed clinically conlmin- 
dicated in an additional four patients kcause of severe 
dementia, neurologic disability or advanced cardiac and 
renal failure. Seven patient> tequired a coronary reopera- 
tioo. four of whom subsequently died and are included 
among the 35 patients who died. Long-term aogiographic 
follow-w was obtained io the remaioiaa 62 patients (47%). 
who c&titute the substance of this report. The cardiovas- 
ctdar risk factors of these 62 oatients are shown in Table 2. 
We reviewed the hospital~records and death certificates 
(wheo available) of patients who died to determine their 
caase of death. These records were available for only 16 of 
the 35 deaths. Of these 16 deaths, 8 were doe to noncard& 
caoses and the other 8 wexe of wdii o&in. The cause of 
death WBS not koown for 19 oatients. 
A predelemdoed miaimal~ote~al of 36 months between 
the initial aad the follow-up aogiogmpbic study was set. 
Corooary aa&mms that fohllled the minimal follow-up 
criteria had been performed for clii indiitions in 47 
(76%) of the 62 patients. The remabda8 15 patients (24%) 
were catled in spwi6caUy for the purpose of this study. 
Written informed coosent was obtakd tiom these 15 pa. 
tieots before their pa&i&on in the stody. Tbe study 
pmtoeol was approved by tie Human Bodies Subcommittee 
of the Veterans AEairs Medii Center. Et&lo on Deam- 
her 16.1988. 
Vda @t -. These 62 patients had a total of 
131 vein maft seaments that were eliaibk for ioxlesian in our 
aoatysir,rresulti~ to ao average $2.2 grafl segmams per 
patient. Forty-three other 8mfta wen excloded becaose of 
the presence of sigoilicant disease. Of the 131 included 
go&, 97 (74%) were proximal segments (aortw) 
aad 34 (26%) were distal seamoats (comaawcomnarvl. The 
avera& ye& of opcrationks lk8 t 2.i years (t&o * 
SD). The initial study occurred a mean of 6.1 f 2.1 years 
after bypass surgery. The mean interval belween the initial 
aad the late foliow~up study was 5.1 k 1.4 years. Therefore, 
at the time of late follow-up, the meao age oftbe vein gafts 
was 11.0 f 2.Oyean. 
&bgmphk methods. Ciaeangiogmms were reviewed 
by at least two of the three authors. AU studies were 
performed in multiple projections, allowing adequate visual- 
ization of all graft segments. Stenotic lesions were qoantikd 
by using caliper measuremeats of stenotic sewn@ and 
adjacent normal or oear aortaal segments. Stenosis severity 
was expressed as pereem lumen diietcr narrowing. if 
several sleaoses were preseot, the most severe lesion was 
reported. Classitication of lesion severity was as follows: 
minimal (~35%). moderate (35% to 69%). severe (70% to 
99%) aad occluded (100%). 
.StatMM aaalys& Clinical, hemodyaamic and aogio- 
graphic diierences were tested for statistical sigoiikaace by 
I tests and chi-square tests as appropriate. A difference was 
considered statistically signilicant at p < 0.05. Multivariate 
analysis of variance wes perfomvzd to identify cardiac risk 
factors, includiag hypart&sion, hypercholestemlemia. dia- 
betes mellitas aad smokina (iadeoeadent variables) that 
corelated with gratl occlusion (d&ndent variable) using 
data from 47 patients for whom complete data were avail- 
able. Tlte statistical analyses were performed using SYSTAT 
(The System for Statistics). 
ROWUS 
CBduJ ehuacIerI’Uks. The clinical profile of the 62 
Iaclttded patients changed minimally between the two stud- 
ies. E’:hty-aim percent of patients reported symptoms of 
angina pectotis at the initial study, and 92% reported similar 
symptoms at follow-up. The high frequency of angina pet- 
tmis reported at both studies ret?ects the fact that aagiogra- 
phy WBS performed largely because of clinical indications. 
usually the presence of angina peftoris. It should be noted 
that patients in Ibis study often had other gratk with 
significaat diseax that were not included in the analysis but 
could weU explain their sympiums. Althuugh 76% uf ptisnts 
had experienced a myocardial infarction before their initial 
study, tbe incidence of advanced letl ventricttlar dyshutction 
(ejection fraction CO.40) was only 13%. Thirty percent of 
&cnts had a myocardial infarction in the interval between 
the two studies. resulting in a decline in the mean left 
venttictdat ejection fraitioiola t?om 0.59 f 0.14 to 0.50 + 0. IS 
(p < WI). However. the percent of patients with advanced 
left ventricular dysfunction remained low (22%). 
wtarztt fate of vela grafts. The angiographic findings 
a~ the time of the late study arc shwn in Figure 2. Fiiy- 
three percent of the vein gift segments remained normal OT 
only mlnImaUy diseased. Moderate stenosis developed in 
1!3%, and severe progression of disease was evident in Ib. 
The rate of total occlusion was 21%. Thus, 79% of graft 
segments remained patent and 71% remained I&e of severe 
disease at S-year follow-up. 
The late angiogmphic rrsults were also examined an the 
basis of outcome per patient, rather than per uat7 (Fig. 3). 
Thirty-one pereeni of-&i&s had no @-a& with more than 
minimal disease. Conversely. 35% of patients had one or 
more totally occluded grafts. The reataiaIag 34% bad mod- 
erstc to severe stenosis in at least one gtafl but au occlu- 
rions. 
m’r examined the effects of the major cardiovascul~ risk 
factors including smoking, hypertension (blmzd pres~urc 
2 160190 mm Ha), diabetes meltitus and hypercholesteml- 
emia (cholesterol a220 m&U) on vein grafl occlusion 
rates. GratI occlusion rates did not d&r sianiicantlv be- 
tween those who did and did not possess a speci6f risk 
factor. Subgroup analysis was also performed OR those 
patients with severe risk factors iacludmg b!ood pressure 
z-2220/110 mm Hg. cholesterol 2300 mg/dl and diet&es 
requiring insulin. Severe hypertension (a = 6) was associ- 
atcd with a higher occlusion rate (86% vs. 13%. p i 0X105), 
whereas patients taking insulin (tt = 7) had a lower occlusion 
rate (0% s. 27%. p < 0.025). No difference was observed 
(p 1 0.5) between those with (n = 5) mad without severe 
hypercbolcsicroktia. Cm multivariate x&is. the otdy 
risk factor that independently conelated with graJtocclusion 
was severe hypene&n (p < 0.W. However, because of 
the small number of oatients in each subgoup, the possibit- 
ity that the observed differences are due to rar.dom events 
cnnttot be excluded. 
Norm01 versus minimally direosedgrafts. An analysis of 
the long-term fate of vein grafts that were previousiy normal 
versus those that had minimal disease is shown in Fiiure 4. 
At the time of the initial study, 80 of the 131 (61%) @-aft 
segments were angiograpbically normal, and 51 (39%1 had 
minimal disease. On S-year follow-up, there was a slight 
trend toward more disease progression among those gmits 
that previously had minimal disease, althouah the differ- 
ences were not statistically significant (p > 0.5). 
Prarimal versus distal &I segments. The data were 
also analyzed for any diietences between proximal (aor@ 
Ftyre 4. Bar graph showing the percent of grafls as a function of 
stenosis severity at follow-up 11.0 t 2.0 years after coronary bypass 
surgery for grafts that were nomul (black txun) and those that had 
minimal disease (pray bars) at initial study 6.1 + 2.1 years after 
coronary bypass suraery. 
coronary) and distal (coronary-coronary) vein graft seg- 
ments IFie. 51. These data indicate that the rates of disease 
pro&&i& are similar between the IWO groups at the time of 
late fcdlow-up (p > 0.9). 
Parency of grafts as a function of fhe ormy grafted. Of 
a tatal of 131 vein graft segments studied, 64 (49%) were 
directed to the left anterior descending and diagonal branches, 
35 (27%) to the letI circumt& and marginal branches (includ- 
ing ramus intermedius) and 32 (24%) to the right cownary 
artery and its distal circulation. AI S-year follow-up, the 
patency rates for vein grafts directed to the letI anterior 
descending, right coronary and letI circttmllex systems were 
86%. 78% and 69%. resoectivelv. There was a treml toward a 
low& patency rate in tie left ci&mRex gmfts, but the ditTer- 
ences did not achieve statistical sigttiticaace (p > 0.1). 
Patency as n funcrion of grafr age (II inirial study and 
duration offollow-up. A final point ofinterest is whether the 
patency of the vein grafts is influenced by either the age of 
Figre 5. Bar graph showing the percent Of grafts as a fUnCtiOn Of 
stenosis severity at follow-up t t.0 t 2.0 years after coronary bypass 
surgery for proximal (black bars) and distal (m tws) graft ssg 
F@wc 6. Bar gqttr siwwk~~ the long-term graft patency rates as a 
function of the age of the grafts at initial study (A) and as a tbnclion 
of the interval duration belween the initial and late f&w-up study 
(s). Numbers in pamdkew indicate number ofgrafts. 
the grail at initial study or the time interval betwem the 
initial and follow-up studies (Fig. 6, A and B). There did not 
appear to be any correlation between the age of the g&s at 
initial study and their late patency rate (Fii. 6AI. Figure 6A 
does not include the eight gifts that were 29 years old 
(range 103 to MS months) at the time of the initial s~ududy as 
there were few of them. It should be noted that the mean 
duration of follow-up of the different gxdI age groups was 
similar (range 53 * 7 to 68 2 17 months). Analysis of @‘atI 
patency rates as d function of the total age of the g&s (from 
coronary bypass surgery to late follow-up study) likewise 
showed no correlation. 
In contrast. Figure 6B shows a trend toward decreasing 
patency as the duration of follow-up increases. However. 
the absolute patency rates in these @‘aIts remain within Ihe 
range of previously observed S- to 7-year patency rates of 
new grafts. Gf three grafts that were resludied 9 years after 
the initial study. two had occluded. 
Discussion 
SummaydEndhgsandmmpa&mnilhotkcsidiu 
Our data indicate that the long-term patency of saphenotts 
vein gaits that have remained angiographically normal or 
rmnimrdly discaed 5 years after operation i5 good. At J-year 
follow-up (zpproximateiy II years &er bypass surgery). 
?Q% are oaten! and 71% are free of severe disease. In fact. 
more than half of the grafts are free of all but minimal 
dlseare. Our occlusion rate of 21% is slightly lower than that 
reported by Campew et al. (4). who found a 26% calwion 
rate in a sub*****~ nf caphenous vein grafts that were patent B.‘“F _.
at 5 to 7 years and restudied IO to I2 vearx after suwry. 
Both of these rates compare favorably wtrh published-vein 
graft occlusion rates during the initial S to 1 years after 
bvpass surgery, which ranees fmm 25% to 35% (I). 
‘In fack. the appropriate-comparison” for our study would 
be lo the long-term patency of newly placed vein gxzfts 
during a secund bypass operaiion when the quality of venous 
conduits. native coronary anatomy and weraIl patient con- 
dition are generally less than optimal. Data from the Cleve- 
land Clinic showed a 26% vein graft occlusion rate at B me”” 
interval of 39 months after a &and coronary bypass oper- 
ation 0). Of note is the shorter follow-w inlerval(35 vs. :hc 
61 months in the present study). In Ii&t of these data. the 
recommendation to replace normal or minimally diseased 
saphenous vein gmfts during late coronary reopenlion 
should be reeveluated. 
Earl? awl late graft failure. Several studies hilve shown 
that saphenous vein grafts ere at risk for early and late graft 
failure (4.6-10). Of particular concern is the 1st year after 
bypass surgery when the occlusion rate msy reach 16% to 
26%. During this early phase, occlusion of vein gratis is 
usually related to technical problems in the preparation and 
implantation of the venous conduits, poor native vessel 
runoff, early thrombosis and diffuse intimal byperplasu 
(6,11.12). The decision to replace a patent vein graft at the 
time of reoperation must rake into considcratioo the risk of 
early occlusion, which would limit the anticipated benefii nf 
reoperation. 
Late graft failure. in contms~. is almost exclusively due to 
progressive atherosclerosis and the complications of athero- 
sclerolic slaaue ruoture (I t-13). Patholocic examination has 
demon&ted ath&clerotic lesions in is many as 71% of 
vein grafts older than 3 years (l?.l3). Furthermore. eve” 
angiognphically normal or minimelly diseased g&s often 
have atherosclerotic involvement (3). It is likely, therefore, 
that atherosclerosis was present in 8 significant proportion of 
the grafts included in this study even if it w”s not angio- 
graphically apparent. Nevenheless, the rate of progression 
of the atherosclerotic orocess in this subset of grafts was 
modest with a S-year patency mte of nearly XG%. One may 
speculate that whatever factors were responsible for the 
early durability of these grafts continue to play an important 
role in retarding the atherosclerotic process many years 
later. 
The long-ten” patency rate of antjogmphically normai 
vein grafts was similar to that of gmfts previously found to 
have minor lumen irregularities. Possible cxplanat~ons for 
this observation we that angiography I:&\ the wxitivity lo 
detect subtle atherosclcrottc change m apparenrly normal 
grafts and that no real diierence exists between the two 
subgroups wiib is& to the presence and extent of athero- 
sclerosis. Nevenhcless. our data indicate that the presence 
of minimal diseae o” angiography, which presumably im- 
plies the prew.nce of nonobstructive atherosclerosis. does 
not adversely influence long-term patency. 
Limitat& of the Srudy; One &nit&n of our study is 
that 35 (27%; of the elitible patients had died before aoom- 
priate follow-up was obtained. An additional seven p&s 
15%) underwent repeat bypass surgery. four of whom SUP 
scqusnrly died. In both of these groups. graft failure may 
have played a” imp~nant role. One way of accounting for 
this would be 10 assume a worst case scenario and assume 
that all cardiac deaths and all deaths of unknown cause were 
due to the occlusion of a vein graft that had been previously 
normal or only minimally diseased. Of the 35 patients who 
died, 8 died of definite noncardiac causes. The other 27 
patients had dted of either confirmed or assumed cardiac 
d;arh (8 cardiac plus 19 unknown). These 27 patients had a 
total of 53 eligible g&s 1 the time of the initial study. lf 
each of these 27 palients died because of a grail occlusion. 
the total number of occluded grafts would double from 27 to 
54. Al the same time. the number of eligible grafts would 
increax from 131 to 184. Therefore. the occlusion rate 
would increase from 21% (.?? of 131) to 29% (54 of I?d), a 
figure thu is slill well within the range of occlusicn rmes of 
new grafts. 
lfonr funher includes the patients who had repat bws 
surgery in thts worst-case scenario. an even more conserva- 
tive cstimatc would rzsult. Four of the seven oatients who 
had repeat bypass surgery subsequently died and are in- 
cluded in the preceding analysis. The three remaining pa- 
tients who underwent a second operation had atotal of seven 
eligible grafts among them. If one assumes that al! 7 ofthess 
grafts failed. the total number of occluded and eligible gifts 
would increase to 61 and 191. respectively. In this theoreti- 
cal siw&n. the occlusion rate of the vein gmfle would be 
32% (61 of 191). Again this occlusion rate is comparable to 
S-year occlusion rates of new gnlts. 
Although the exclusionofpatients whodied or underwent 
a second operation would underestimate the true occlusion 
rate. Ihc high mcidcnce of an&al symptoms among our 
patients (92%) would bias the results in the opposite direc- 
tion and yield 8 higher graft ailure rate. Converseiy. patients 
who we asympromatic or only mildly symptomatic are likely 
to have a higher graft patertcy rate. in fact, the majority of 
the patients who refused to undergo a follow-up caronW 
angiogram and were thus excluded from thts study did so 
because of lack of symptoms. One might postulate that the 
exclwion of this subset of patients would bias rhe data in 
fwor of a higher occlusion rate. 
Anolhcr factor that could intluence rhe patency of vein 
grafts is Ihe use of antiplatelet medications. In this study, 
information on the use of these agents was incomplete and 
therefore not included in the data. Although anliplatelet 
itgc”ts have been shown to improve early (<3 yeai-sJ vein 
graft patency rates (141, the value of these drugs in older 
@afts (>5 yeas) has not been established (2,15). 
Technical amsideratimts. Finally, in detemGing whether 
to replace an an&raphicaUy normal or minimally diseased 
S-year old graft at the time of reopcmticm, one must consider 
technical factors such as the additional operative and 
“pump” time required to expose target vessels and to 
construct new ven~u.s conduits. as well as the risk of 
embolization of gmtl debris due to manipulation of the heart. 
One mieht minimize such risk bv avoidine areas that do not 
clearly need to be manipulated.S - 
Conclusiona. This study demonstrates that the long-term 
patency of zmgiogmphically nomul or minimally diseased 
win gifts is good with a 7% S-yea patency rate and with 
71% of grafts remaining free of severe disease over the same 
period. The presence of minimal atherosclerosis does not 
adversely affect long-temt patency. Thus, the recommenda- 
tion to replace normal or minimally diseased vein grafts 
during late reoperation should be reevaluated. 
